Insulin signaling regulates cardiac titin properties in heart development and diabetic cardiomyopathy

Journal of Molecular and Cellular Cardiology

Volumn 48, Issue 5, 2010, Pages 910-916

  Krüger, Martina ^a   Babicz, Kamila ^a,b   von Frieling Salewsky, Marion ^a   Linke, Wolfgang A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Diabetes; Diastolic dysfunction; Heart failure with preserved ejection fraction; Myocardial stiffness; Passive tension

Indexed keywords

CONNECTIN; GLUCOSE; INSULIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DIABETIC CARDIOMYOPATHY; DIASTOLIC DYSFUNCTION; EMBRYO; ENZYME ACTIVATION; FEMALE; GLUCOSE BLOOD LEVEL; HEART DEVELOPMENT; HEART HYPERTROPHY; HEART MUSCLE CELL; HEART MUSCLE COMPLIANCE; HEART MUSCLE FIBROSIS; IN VIVO STUDY; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANIMALS; CARDIOMYOPATHIES; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; HEART; HEART FAILURE; INSULIN; MUSCLE PROTEINS; MYOCARDIUM; MYOCYTES, CARDIAC; PHOSPHORYLATION; PREGNANCY; PROTEIN KINASES; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

RATTUS;

EID: 77951620454     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2010.02.012     Document Type: Article

References (37)

1. Linke W.A. Sense and stretchability: the role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 2008, 77(4):637-648.
2. Freiburg A., Trombitas K., Hell W., Cazorla O., Fougerousse F., Centner T., et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res 2000, 86:1114-1121.
3. Bang M.L., Centner T., Fornoff F., Geach A.J., Gotthardt M., McNabb M., et al. The complete gene sequence of titin, expression of an unusual approximately 700-kDa titin isoform, and its interaction with obscurin identify a novel Z-line to I-band linking system. Circ Res 2001, 89:1065-1072.
4. Krüger M., Linke W.A. Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 2009, 46:490-498.
5. Opitz C.A., Leake M.C., Makarenko I., Benes V., Linke W.A. Developmentally regulated switching of titin size alters myofibrillar stiffness in the perinatal heart. Circ Res 2004, 94:967-975.
6. Warren C.M., Krzesinski P.R., Campbell K.S., Moss R.L., Greaser M.L. Titin isoform changes in rat myocardium during development. Mech Dev 2004, 121:1301-1312.
7. Kruger M., Kohl T., Linke W.A. Developmental changes in passive stiffness and myofilament Ca2+ sensitivity due to titin and troponin-I isoform switching are not critically triggered by birth. Am J Physiol Heart Circ Physiol 2006, 291:H496-H506.
8. Neagoe C., Kulke M., del Monte F., Gwathmey J.K., de Tombe P.P., Hajjar R.J., et al. Titin isoform switch in ischemic human heart disease. Circulation 2002, 106:1333-1341.
9. Nagueh S.F., Shah G., Wu Y., Torre-Amione G., King N.M., Lahmers S., et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 2004, 110:155-162.
10. Makarenko I., Opitz C.A., Leake M.C., Neagoe C., Kulke M., Gwathmey J.K., et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 2004, 95:708-716.
11. Wu Y., Peng J., Campbell K.B., Labeit S., Granzier H. Hypothyroidism leads to increased collagen-based stiffness and re-expression of large cardiactitin isoforms with high compliance. J Mol Cell Cardiol 2007, 42(1):186-195.
12. Klein I., Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344:501-509.
13. Kruger M., Sachse C., Zimmermann W.H., Eschenhagen T., Klede S., Linke W.A. Thyroid hormone regulates developmental titin isoform transitions via the phosphatidylinositol-3-kinase/AKT pathway. Circ Res 2008, 102:439-447.
14. Dillmann W.H. Cellular action of thyroid hormone on the heart. Thyroid 2002, 12:447-452.
15. Harvey C.B., Williams G.R. Mechanism of thyroid hormone action. Thyroid 2002, 12:441-446.
16. Warren C.M., Krzesinski P.R., Greaser M.L. Vertical agarose gel electrophoresis and electroblotting of high-molecular-weight proteins. Electrophoresis 2003, 24:1695-1702.
17. Prado L.G., Makarenko I., Andresen C., Kruger M., Opitz C.A., Linke W.A. Isoform diversity of giant proteins in relation to passive and active contractile properties of rabbit skeletal muscles. J Gen Physiol 2005, 126:461-480.
18. Li H., Linke W.A., Oberhauser A.F., Carrion-Vazquez M., Kerkvliet J.G., Lu H., et al. Reverse engineering of the giant muscle protein titin. Nature 2002, 418:998-1002.
19. Machackova J., Barta J., Dhalla N.S. Molecular defects in cardiac myofibrillar proteins due to thyroid hormone imbalance and diabetes. Can J Physiol Pharmacol 2005, 83:1071-1091.
20. Hsu K.L., Tsai C.H., Chiang F.T., Lo H.M., Tseng D., Wang S.M., et al. Myocardial mechanics and titin in experimental insulin-resistant rats. Jpn Heart J 1997, 38(5):717-728.
21. Belke D.D., Betuing S., Tuttle M.J., Graveleau C., Young M.E., Pham M., et al. Insulin signaling coordinately regulates cardiac size, metabolism, and contractile protein isoform expression. J Clin Invest 2002, 109(5):629-639.
22. Aldoretta P.W., Carver T.D., Hay W.W. Maturation of glucose-stimulated insulin secretion in fetal sheep. Biol Neonate 1998, 73(6):375-386.
23. Ma M.X., Blenis J. Molecular mechanisms of mTOR-mediated translational control. Nat Rev 2009, 10:307-318.
24. Dennis P.B., Fumagalli S., Thomas G. Target of rapamycin (TOR): balancing the opposing forces of protein synthesis and degradation. Curr Opin Genet Dev 1999, 9:49-54.
25. Litwin S.E., Raya R.E., Anderson P.G., Daugherty S., Goldman S. Abnormal cardiac function in the streptozotocin-diabetic rat. Changes in active and passive properties of the left ventricle. J Clin Invest 1990, 86:481-488.
26. Akula A., Kota M.K., Gopisetty S.G., Chitrapu R.V., Kalagara M., Kalagara S., et al. Biochemical, histological and echocardiographic changes during experimental cardiomyopathy in STZ-induced diabetic rats. Pharmacol Res 2003, 48(5):429-435.
27. Dhalla N.S., Liu X., Panagia V., Takeda N. Subcellular remodeling and heart dysfunction in chronic diabetes. Cardiovasc Res 1998, 40:239-247.
28. Krüger M., Linke W.A. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil 2006, 27:435-444.
29. Krüger M., Kötter S., Grützner A., Lang P., Andresen C., Butt-Dörje E., et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 2009, 104:87-94.
30. Borbely A., van der Velden J., Papp Z., Bronzwaer J.G., Edes I., Stienen G.J., et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005, 111:774-781.
31. Hidalgo C., Hudson B., Bogomolovas J., Zhu Y., Anderson B., Greaser M., et al. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 2009, 105(7):631-638.
32. Grützner A., Garcia-Manyes S., Kötter S., Badilla C.L., Fernandez J.M., Linke W.A. Modulation of titin-based stiffness by disulfide bonding in the cardiac titin N2-B unique sequence. Biophys J 2009, 97(3):825-834.
33. Zeng G., Nystrom F., Ravichandran L.V., Cong L.N., Kirby M., Mostowski H., et al. Roles for insulin receptor, PI3-Kinase, and Akt in insulin-signaling pathways related to production of nitric oxide in human vascular endothelial cells. Circulation 2000, 101:1539-1545.
34. Abdallah Y., Gkatzoflia A., Gligorievski D., Kasseckert S., Euler G., Schlüter K.D., et al. Insulin protects cardiomyocytes against reoxygenation-induced hypercontracture by a survival pathway targeting SR Ca2± storage. Cardiovasc Res 2006, 70:346-353.
35. Sarbassov D.D., Ali S.M., Kim D.H., Guertin D.A., Latek R.R., Erdjument-Bromage H., et al. Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton. Curr Biol 2004, 14(14):1296-1302.
36. van Heerebeek L., Hamdani N., Handoko L., Falcao-Pires I., Musters R.J., Kupreishvili K., et al. Diastolic stiffness of the failing diabetic heart. Importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008, 117:43-51.
37. Radovits T., Korkmaz S., Loganathan S., Barnucz E., Bömicke T., Arif R., et al. Comparative investigation of the left ventricular pressure-volume relationship in rat models of type 1 and type 2 diabetes mellitus. Am J Physiol 2009, 297:H125-H133.